The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation
Abstract
In an effort to attain earlier diagnoses in children with hemophagocytic lymphohistiocytosis (HLH), the International Histiocyte Society has now broadened their diagnostic criteria to no longer differentiate primary (HLH) and secondary hemophagocytic lymphohistiocytosis (SHLH). Five of the following eight diagnostic criteria needed to be met: 1) fever, 2) cytopenia of two lines, 3) hypertriglyceridemia and/or hypofibrinogenemia, 4) hyperferritinemia (>500 microg/L), 5) hemophagocytosis, 6) elevated soluble interleukin-2 receptor (CD25), 7) decreased natural killer-cell activity, and 8) splenomegaly can also commonly be found in patients with sepsis, systemic inflammatory response syndrome (SIRS), multiorgan dysfunction syndrome (MODS), and macrophage activation syndrome (MAS). Nevertheless, the therapeutic options for these are radically different. Chemotherapy and bone marrow transplant have been used for treatment of HLH/SHLH, whereas antibiotics and supportive treatment are used in severe sepsis/SIRS and MODS. MAS is treated with limited immune suppression. Outcomes are also different, SHLH has a mortality rate around 50%, whereas pediatric septic shock and MODS have a mortality of 10.3% and 18%, respectively, and severe sepsis in previously healthy children has a mortality rate of 2%. MAS has a mortality rate between 8% and 22%. Because SHLH and severe sepsis/SIRS/MODS/MAS share clinical and laboratory inflammatory phenotypes, we recommend extreme caution when considering applying HLH therapies to children with sepsis/SIRS/MODS/MAS. HLH therapies are clearly warranted for children with HLH; however, a quantitative functional estimate of cytotoxic lymphocyte function may be a more precise approach to define the overlap of these conditions, better identify these processes, and develop novel therapeutic protocols that may lead to improved treatments and outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Henter, J., Horne, A., Aricó, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J., et al. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21039 · Cited by 5,386
Heme oxygenase-1: unleashing the protective properties of heme
Otterbein, L. E., Soares, M. P., Yamashita, K., & Bach, F. H. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00181-9 · Cited by 1,166
Feldmann, J., Callebaut, I., Raposo, G., Certain, S., Bacq, D., Dumont, C., Lambert, N., Ouachée-Chardin, M., Chedeville, G., Tamary, H., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00855-9 · Cited by 943
Henter, J.-I. (2002) · Blood · doi:10.1182/blood-2002-01-0172 · Cited by 900
Henter, J., Elinder, G., & Öst, Å. (1991) · PubMed · Cited by 761
Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis
Allen, C. E., Yu, X., Kozinetz, C. A., & McClain, K. L. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21423 · Cited by 634
Perforin-mediated target-cell death and immune homeostasis
Voskoboinik, I., Smyth, M. J., & Trapani, J. A. (2006) · Nature reviews. Immunology · doi:10.1038/nri1983 · Cited by 592
Familial hemophagocytic lymphohistiocytosis
Janka, G. E. (1983) · European Journal of Pediatrics · doi:10.1007/bf00443367 · Cited by 578
Aricò, M., Janka, G., Fischer, A., Henter, J., Blanche, S., Elinder, G., Martinetti, M., & Rusca, M. P. (1996) · PubMed · Cited by 468
Janka, G. E. (2007) · Blood Reviews · doi:10.1016/j.blre.2007.05.001 · Cited by 454
Bleesing, J., Prada, A., Siegel, D. M., Villanueva, J., Olson, J., Ilowite, N. T., Brunner, H. I., Griffin, T., Graham, T. B., Sherry, D. D., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22416 · Cited by 321
Grom, A. A., Villanueva, J., Lee, S., Goldmuntz, E. A., Passo, M. H., & Filipovich, A. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.110 · Cited by 284
Imashuku, S. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00117-8 · Cited by 271
Delivering the kiss of death: progress on understanding how perforin works
Pipkin, M. E., & Lieberman, J. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.04.011 · Cited by 263
Odetola, F. O., Gebremariam, A., & Freed, G. L. (2007) · Pediatrics · doi:10.1542/peds.2006-2353 · Cited by 241
Pathogenesis of haemophagocytic lymphohistiocytosis
Aricò, M., Danesino, C., Pende, D., & Moretta, L. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02936.x · Cited by 235
Modern management of children with haemophagocytic lymphohistiocytosis
Janka, G. E., & Schneider, E. M. (2004) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04726.x · Cited by 235
Pathogenesis of hemophagocytic syndrome (HPS)
Larroche, C., & Mouthon, L. (2004) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00091-0 · Cited by 221
Arlet, J.-B., Le Thi Huong, D., Marinho, A., Amoura, Z., Wechsler, B., Papo, T., & Piette, J.-C. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.046904 · Cited by 219
Berberat, P. O., Katori, M., Kaczmarek, E., Anselmo, D., Lassman, C., Ke, B., Shen, X., Busuttil, R. W., Yamashita, K., Csizmadia, E., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0229fje · Cited by 207
Mortality rates in pediatric septic shock with and without multiple organ system failure
Kutko, M. C., Calarco, M. P., Flaherty, M. B., Helmrich, R. F., Ushay, H. M., Pon, S., & Greenwald, B. M. (2003) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000074266.10576.9b · Cited by 201
Lipoproteins in inflammation and sepsis. II. Clinical aspects
Wendel, M., Paul, R., & Heller, A. R. (2007) · Intensive Care Medicine · doi:10.1007/s00134-006-0433-x · Cited by 194
Tuberculosis-associated haemophagocytic syndrome
Brastianos, P. K., Swanson, J. W., Torbenson, M., Sperati, J., & Karakousis, P. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70524-2 · Cited by 182
Lipoproteins in inflammation and sepsis. I. Basic science
Murch, O., Collin, M., Hinds, C. J., & Thiemermann, C. (2007) · Intensive Care Medicine · doi:10.1007/s00134-006-0432-y · Cited by 180
HASHIMOTO, S., KOBAYASHI, A., KOOGUCHI, K., KITAMURA, Y., ONODERA, H., & NAKAJIMA, H. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.1.9810007 · Cited by 173
Perforin and Granzymes Have Distinct Roles in Defensive Immunity and Immunopathology
van Dommelen, S. L. H., Sumaria, N., Schreiber, R. D., Scalzo, A. A., Smyth, M. J., & Degli-Esposti, M. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.010 · Cited by 171
Strauss, R., Neureiter, D., Westenburger, B., Wehler, M., Kirchner, T., & Hahn, E. G. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000127779.24232.15 · Cited by 157
Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?
Grom, A. A. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200309000-00011 · Cited by 148
Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163*
Møller, H. J., Moestrup, S. K., Weis, N. M., Wejse, C. M., Nielsen, H. I., Pedersen, S. S., Attermann, J., Nexø, E., & Kronborg, G. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000239120.32490.ab · Cited by 133
Macrophage activation syndrome--what's in a name!
Ramanan, A. V., & Schneider, R. (2003) · PubMed · Cited by 119
Voves, C., Wuillemin, W. A., & Zeerleder, S. S. (2006) · Blood Coagulation & Fibrinolysis · doi:10.1097/01.mbc.0000240916.63521.2e · Cited by 113
Plasma exchange as rescue therapy in multiple organ failure including acute renal failure*
Stegmayr, B. G., Banga, R., Berggren, L., Norda, R., Rydvall, A., & Vikerfors, T. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000064742.00981.14 · Cited by 111
Immunomodulation treatment for childhood virus‐associated haemophagocytic lymphohistiocytosis
Chen, R., Lin, K., Lin, D., Su, I., Huang, L., Lee, P., Hseih, K., Lin, K., & Lee, C. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb03302.x · Cited by 111
Imashuku, S., Teramura, T., Tauchi, H., Ishida, Y., Otoh, Y., Sawada, M., Tanaka, H., Watanabe, A., Tabata, Y., Morimoto, A., et al. (2004) · PubMed · Cited by 99
Suppression of natural killer-cell function in humans following thermal and traumatic injury
Blazar, B. A., Rodrick, M. L., OʼMAHONY, J. B., Wood, J. J., Bessey, P. Q., Wilmore, D. W., & Mannick, J. A. (1986) · Journal of Clinical Immunology · doi:10.1007/bf00915361 · Cited by 90
Samra, J. S., Summers, L., & Frayn, K. (1996) · British Journal of Surgery · doi:10.1046/j.1365-2168.1996.02445.x · Cited by 90
Abraham, N. G., & Drummond, G. (2006) · Circulation Research · doi:10.1161/01.res.0000249616.10603.d6 · Cited by 87
Matsumoto, Y., Naniwa, D., Banno, S., & Sugiura, Y. (1998) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.1998.tb00127.x · Cited by 85
Hemophagocytic macrophages constitute a major compartment of heme oxygenase expression in sepsis
Schaer, D. J., Schaer, C. A., Schoedon, G., Imhof, A., & Kurrer, M. O. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00730.x · Cited by 85
Hematologic Changes in Sepsis and Their Therapeutic Implications
Goyette, R. E., Key, N. S., & Ely, E. W. (2004) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2004-860979 · Cited by 83
Substrate utilization/insulin resistance in sepsis/trauma
Wolfe, R. R. (1997) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(97)80926-3 · Cited by 81
Koduri, P. R., Chundi, V. V., Demarais, P., Mizock, B. A., Patel, A. R., & Weinstein, R. A. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1463 · Cited by 73
Macrophage activation syndrome in juvenile idiopathic arthritis
Cortis, E., & Insalaco, A. (2006) · Acta Paediatrica · doi:10.1080/08035320600649713 · Cited by 68
ALTERED LEVELS AND MOLECULAR FORMS OF GRANZYME K IN PLASMA FROM SEPTIC PATIENTS
Ručević, M., Fast, L. D., Jay, G. D., Trespalcios, F. M., Sucov, A., Siryaporn, E., & Lim, Y. (2007) · Shock · doi:10.1097/01.shk.0000246905.24895.e5 · Cited by 67
Addressing the mysteries of perforin function
Voskoboinik, I., & Trapani, J. A. (2006) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01409.x · Cited by 62
Sharkey, R., Donnelly, S. C., Connelly, K. G., ROBERTSON, C. E., Haslett, C., & Repine, J. E. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.5.9809027 · Cited by 62
Platz, K., Mueller, A. R., Rossaint, R., ller, T. S., Lemmens, H. P., Lobeck, H., & Neuhaus, P. (1996) · Transplantation · doi:10.1097/00007890-199611270-00011 · Cited by 60
sFas and sFas Ligand and Pediatric Sepsis-Induced Multiple Organ Failure Syndrome
Doughty, L., Clark, R. S. B., Kaplan, S. S., Sasser, H. C., & Carcillo, J. A. (2002) · Pediatric Research · doi:10.1203/00006450-200212000-00018 · Cited by 60
Self-citationHsieh, S., & Chang, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4530 · Cited by 52
Plasma Therapies in Thrombotic Syndromes
Nguyen, T. C., Stegmayr, B. G., Busund, R., Bunchman, T. E., & Carcillo, J. A. (2005) · The International Journal of Artificial Organs · doi:10.1177/039139880502800506 · Cited by 42
Self-citationMacrophage activation syndrome and other systemic inflammatory conditions after BMT
Sreedharan, A., Bowyer, S. L., Wallace, C. A., Robertson, M. J., Schmidt, K. M., Woolfrey, A. E., & NELSON, R. P. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705305 · Cited by 42
Hemophagocytic Lymphohistiocytosis: An Unusual Initial Presentation of Acute HIV Infection
Sun, H., Chen, M.-Y., Fang, C., Hsieh, S., Hung, C., & Chang, S. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000136725.92886.b8 · Cited by 40
Kuwata, K., Yamada, S. M., Kinuwaki, E., Naito, M., & Mitsuya, H. (2006) · Shock · doi:10.1097/01.shk.0000209520.82377.41 · Cited by 38
Hampson, F. (2005) · Archives of Disease in Childhood · doi:10.1136/adc.2005.075028 · Cited by 38
A proteomic analysis of liver mitochondria during acute endotoxemia
Crouser, E. D., JULIAN, M. W., Huff, J. E., Mandich, D. V., & Green‐Church, K. B. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0224-4 · Cited by 34
Hemophagocytic Lymphohistiocytosis Complicating Influenza A Infection
Mou, S. S., Nakagawa, T. A., Riemer, E. C., McLean, T. W., Hines, M. H., & Shetty, A. K. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1861 · Cited by 32
Satomi, A., Nagai, S., Nagai, T., et al. (1999) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.1999.00209.x · Cited by 29
Haemophagocytic syndrome associated with hepatitis-B virus infection responding to etoposide
Aleem, A., AMOUDI, S. A., Al-Mashhadani, S. A., & Siddiqui, N. (2005) · Clinical & Laboratory Haematology · doi:10.1111/j.1365-2257.2005.00728.x · Cited by 25
Hemophagocytic syndrome associated with visceral leishmaniasis
Agarwal, S., Narayan, S., Sharma, S., et al. (2006) · The Indian Journal of Pediatrics · doi:10.1007/bf02758574 · Cited by 24
Linenberger, M. L., & Price, T. H. (2005) · Journal of Intensive Care Medicine · doi:10.1177/0885066604273479 · Cited by 21
Etoposide‐related secondary acute myeloid leukemia (t‐AML) in hemophagocytic lymphohistiocytosis
Imashuku, S. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.21082 · Cited by 18
Ito, S., Takada, N., Ozasa, A., et al. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1535 · Cited by 17
Estlin, E., Palmer, R. D., Windebank, K., Lowry, M. F., & Pearson, A. (1996) · Archives of Disease in Childhood · doi:10.1136/adc.75.5.432 · Cited by 10
[Immunological defects in septic shock. Deficiency of natural Killer cells and T-lymphocytes].
Puente, J., Miranda, D., Gaggero, A. A., et al. (1991) · PubMed · Cited by 2
Cited by
Adult haemophagocytic syndrome
Ramos-Casals, M., Brito-Zerón, P., López-Guillermo, A., Khamashta, M. A., & Bosch, X. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61048-x · Cited by 1,442
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
La Rosée, P., Horne, A., Hines, M., von Bahr Greenwood, T., Machowicz, R., Berliner, N., Birndt, S., Gil-Herrera, J., Girschikofsky, M., Jordan, M. B., et al. (2019) · Blood · doi:10.1182/blood.2018894618 · Cited by 1,108
Sepsis: a roadmap for future research
Cohen, J., Vincent, J.-L., Adhikari, N. K. J., Machado, F. R., Angus, D. C., Calandra, T., Jaton, K., Giulieri, S., Delaloye, J., Opal, S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70112-x · Cited by 992
Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis
Coomes, E. A., & Haghbayan, H. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2141 · Cited by 883
Serum ferritin: Past, present and future
Wang, W., Knovich, M. A., Coffman, L. G., Torti, F. M., & Torti, S. V. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.03.011 · Cited by 879
Metadata
- Authors
- Castillo, L., & Carcillo, J.
- Venue
- Pediatric Critical Care Medicine
- Published
- 2009-05
- Volume
- 10
- Issue
- 3
- Pages
- 387-392
- ISSN
- 1529-7535 (ISSN-L)
- OpenAlex
- W2059766682
- Cited by
- 271
- References
- 64
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.